Optimization of Antibacterial Peptides by Genetic Algorithms and Cheminformatics
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Pathogens resistant to available drug therapies are a pressing global health problem. Short, cationic peptides represent a novel class of agents that have lower rates of drug resistance than derivatives of current antibiotics. Previously, we created a software system utilizing artificial neural networks that were trained on quantitative structure‐activity relationship descriptors calculated for a total of 1400 synthetic peptides for which antibacterial activity was determined. Using the trained system, we correctly identified additional peptides with activity of 94% accuracy; active peptides were 47 of the top rated 50 peptides chosen from an in silico library of nearly 100 000 sequences. Here, we report a method of generating candidate peptide sequences using the heuristic evolutionary programming method of genetic algorithms (GA), which provided a large (19‐fold) improvement in identification of novel antibacterial peptides. Approximately 0.50% of peptides evaluated during the GA method were classified as highly active, while only 0.026% of the nearly 100 000 sequences we previously screened were classified as highly active. A selection of these peptides was tested in vitro and activities reported here. While GA significantly improves the possibility of identifying candidate peptides, we encountered important pitfalls to this method that should be considered when using GA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cherkasov, A. (2005) · International Journal of Molecular Sciences · doi:10.3390/i6010063 · Cited by 39 · cited 1×
“In addition to peptide studies, these have been successfully applied to a number of molecular modeling studies, including identification of antibacterial activity of small compounds (11) and classification of antimicrobial compounds, conventional drugs, and drug-like substances (12,13).”
BackgroundSelf-citation
Cited by
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Self-citationDesigning antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Self-citationBahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
Self-citationAccelerated antimicrobial discovery via deep generative models and molecular dynamics simulations
Das, P., Sercu, T., Wadhawan, K., Padhi, I., Gehrmann, S., Cipcigan, F., Chenthamarakshan, V., Strobelt, H., dos Santos, C., Chen, P.-Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00689-x · Cited by 414
Metadata
- Authors
- Fjell, C. D., Jenssen, H., Cheung, W. A., Hancock, R. E. W., & Cherkasov, A.
- Venue
- Chemical Biology & Drug Design
- Publisher
- Wiley
- Published
- 2010-10-13
- Volume
- 77
- Issue
- 1
- Pages
- 48-56
- ISSN
- 1747-0277 (ISSN-L)
- 1747-0285
- OpenAlex
- W1486212524
- Cited by
- 96
- References
- 1
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimization of Antibacterial Peptides by Genetic Algorithms and Cheminformatics. https://app.cochat.ai/papers/10.1111/j.1747-0285.2010.01044.x
- The paper
- Fjell, C. D., Jenssen, H., Cheung, W. A., Hancock, R. E. W., & Cherkasov, A. (2011). Optimization of Antibacterial Peptides by Genetic Algorithms and Cheminformatics. Chemical Biology & Drug Design. https://doi.org/10.1111/j.1747-0285.2010.01044.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.